论文部分内容阅读
目的探讨干扰素超声雾化吸入(简称雾吸)对治疗喘息性支气管炎的疗效。方法将本院2008年3月—2009年3月收治的110例喘息性支气管炎患者,随机分为研究组和对照组各55例,分别采用干扰素超声雾化吸入法和肌内注射法治疗,观察两组患者症状改善情况和住院天数。结果研究组湿啰音和喘鸣音消失时间分别为(2.1±0.7)d,(3.4±0.5)d,住院时间为(4.3±0.8)d,明显少于对照组的(4.6±1.3)d,(7.5±1.6)d,(8.5±0.8)d,两组差异有统计学意义(P<0.05)。结论干扰素雾化吸入对于治疗喘息性支气管炎疗效好,症状消失快,值得临床应用推广。
Objective To investigate the efficacy of interferon inhalation (inhalation for short) on asthmatic bronchitis. Methods A total of 110 patients with asthmatic bronchitis treated in our hospital from March 2008 to March 2009 were randomly divided into study group and control group, with 55 cases in each group. The patients were treated with interferon injection and intramuscular injection respectively , To observe the two groups of patients to improve the symptoms and hospitalization days. Results The disappearance time of dampness and wheeze were (2.1 ± 0.7) days and (3.4 ± 0.5) days in hospital and 4.3 ± 0.8 days in hospital and 4.6 ± 1.3 days in control group , (7.5 ± 1.6) d, (8.5 ± 0.8) d, respectively. The difference between the two groups was statistically significant (P <0.05). Conclusion Interferon inhalation is effective in treating asthmatic bronchitis and its symptoms disappear quickly. It is worth to be popularized in clinical application.